Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

IP-10 induces dissociation of newly formed blood vessels.

Bodnar RJ, Yates CC, Rodgers ME, Du X, Wells A.

J Cell Sci. 2009 Jun 15;122(Pt 12):2064-77. doi: 10.1242/jcs.048793. Epub 2009 May 26.

2.

Delayed reepithelialization and basement membrane regeneration after wounding in mice lacking CXCR3.

Yates CC, Whaley D, Hooda S, Hebda PA, Bodnar RJ, Wells A.

Wound Repair Regen. 2009 Jan-Feb;17(1):34-41. doi: 10.1111/j.1524-475X.2008.00439.x.

3.

Calcineurin inhibitors modulate CXCR3 splice variant expression and mediate renal cancer progression.

Datta D, Contreras AG, Grimm M, Waaga-Gasser AM, Briscoe DM, Pal S.

J Am Soc Nephrol. 2008 Dec;19(12):2437-46. doi: 10.1681/ASN.2008040394. Epub 2008 Oct 2.

4.

ELR-negative CXC chemokine CXCL11 (IP-9/I-TAC) facilitates dermal and epidermal maturation during wound repair.

Yates CC, Whaley D, Y-Chen A, Kulesekaran P, Hebda PA, Wells A.

Am J Pathol. 2008 Sep;173(3):643-52. doi: 10.2353/ajpath.2008.070990. Epub 2008 Jul 31.

5.

Epidermal growth factor protects fibroblasts from apoptosis via PI3 kinase and Rac signaling pathways.

Shao H, Yi XM, Wells A.

Wound Repair Regen. 2008 Jul-Aug;16(4):551-8. doi: 10.1111/j.1524-475X.2008.00402.x.

6.

Is there an ideal animal model to study hypertrophic scarring?

Ramos ML, Gragnani A, Ferreira LM.

J Burn Care Res. 2008 Mar-Apr;29(2):363-8. doi: 10.1097/BCR.0b013e3181667557. Review.

PMID:
18354295
7.

Review of the female Duroc/Yorkshire pig model of human fibroproliferative scarring.

Zhu KQ, Carrougher GJ, Gibran NS, Isik FF, Engrav LH.

Wound Repair Regen. 2007 Sep-Oct;15 Suppl 1:S32-9. Review. Erratum in: Wound Repair Regen. 2008 Jul-Aug;16(4):582.

8.
9.

Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing.

Chamberlain G, Fox J, Ashton B, Middleton J.

Stem Cells. 2007 Nov;25(11):2739-49. Epub 2007 Jul 26. Review.

10.

Delayed and deficient dermal maturation in mice lacking the CXCR3 ELR-negative CXC chemokine receptor.

Yates CC, Whaley D, Kulasekeran P, Hancock WW, Lu B, Bodnar R, Newsome J, Hebda PA, Wells A.

Am J Pathol. 2007 Aug;171(2):484-95. Epub 2007 Jun 28.

11.

Mechanical load initiates hypertrophic scar formation through decreased cellular apoptosis.

Aarabi S, Bhatt KA, Shi Y, Paterno J, Chang EI, Loh SA, Holmes JW, Longaker MT, Yee H, Gurtner GC.

FASEB J. 2007 Oct;21(12):3250-61. Epub 2007 May 15. Erratum in: FASEB J. 2011 Oct;25(10):3751.

PMID:
17504973
12.

Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha.

Gallagher KA, Liu ZJ, Xiao M, Chen H, Goldstein LJ, Buerk DG, Nedeau A, Thom SR, Velazquez OC.

J Clin Invest. 2007 May;117(5):1249-59.

13.

Gene expression of tenascin is altered in normal scars and keloids.

Sible JC, Rettig WJ, Eriksson E, Smith SP, Oliver N.

Wound Repair Regen. 1995 Jan-Mar;3(1):37-48.

PMID:
17168861
14.
15.

Circulating endothelial progenitor cells.

Garmy-Susini B, Varner JA.

Br J Cancer. 2005 Oct 17;93(8):855-8. Review.

16.

Fibroblast differentiation of bone marrow-derived cells during wound repair.

Opalenik SR, Davidson JM.

FASEB J. 2005 Sep;19(11):1561-3. Epub 2005 Jul 12.

PMID:
16014399
17.
18.

Histopathological differential diagnosis of keloid and hypertrophic scar.

Lee JY, Yang CC, Chao SC, Wong TW.

Am J Dermatopathol. 2004 Oct;26(5):379-84.

PMID:
15365369
19.

Extracellular matrix signaling through growth factor receptors during wound healing.

Tran KT, Griffith L, Wells A.

Wound Repair Regen. 2004 May-Jun;12(3):262-8. Review.

PMID:
15225204
20.

CXC chemokines: the regulatory link between inflammation and angiogenesis.

Romagnani P, Lasagni L, Annunziato F, Serio M, Romagnani S.

Trends Immunol. 2004 Apr;25(4):201-9. Review. No abstract available.

PMID:
15039047

Supplemental Content

Support Center